Vera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Vera Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2022 to Q3 2025.
  • Vera Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending September 30, 2025 was $254K.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Vera Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $254K Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $254K Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $254K Mar 31, 2025 10-Q 2025-05-07
Q4 2024 $995K +$995K Dec 31, 2024 10-K 2025-02-28
Q4 2023 $0 $0 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $0 $0 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $0 $0 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $0 $0 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $0 Dec 31, 2022 10-K 2023-03-28
Q3 2022 $0 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $0 Mar 31, 2022 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.